Share the Video:

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

Phil Wolfson

KAP extends the possibilities for treating adolescents suffering with a variety of emotional problems. We describe our program, its family centered modality, and the successes and failures of this complex and innovative work

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Effects of psilocybin-assisted psychotherapy on personality and their relationship with self-compassion among individuals with alcohol use disorder

Psilocybin study shows personality changes and increased self-compassion in alcohol use disorder patients. Larger studies needed to confirm impact on AUD outcomes.

Broc A Pagni

PS2023 Health Conditions Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Therapy Ethics

Emerging research on psychedelic therapies for the treatment of pain

Neurological disorders like chronic pain and Alzheimer’s are being studied for psychedelic therapy benefits, expanding research beyond traditional mental health applications. Current studies explore potential applications for neurorehabilitation.

Julia Bornemann, James Close, Joel Castellanos, Robin Carhart-Harris

PS2023 Depression Health Conditions Ketamine Psychedelic Assisted Therapy Psychedelic Science Research and Science

A trial of ketamine masked by surgical anesthesia in depressed patients

Ketamine and other psychedelics show promise for psychiatric disorders, but their psychoactive effects complicate masking in trials. A triple-masked trial on 40 patients with depression found surprising results.

Boris D. Heifets

PS2023 Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science Therapy Ethics

Panel discussion on psilocybin therapy for cancer patients and palliative care

Dr. Smith and Dr. Jones explore the latest research on psychedelic therapy and its potential impact on mental health during the PS2023 conference.

Stacy Fischer, Anthony “Tony” Bossis, Charles S Grob, Manish Agrawal, Shoshana Ungerleider

PS2023 Depression Harm Reduction Ketamine Mental Health Psychedelic Assisted Therapy Research and Science

Panel discussion: The state of ketamine-assisted therapy

Ketamine, a WHO essential medicine, has long been used globally as an anesthetic. Its off-label use for depression is growing, sparking discussions on efficacy, safety, and regulation.

Raquel Bennet, Sunny Strasburg, Gita Vaid, Danielle M Herrera, Lauren Taus

PS2023 Harm Reduction Health Equity Policy and Advocacy Psychedelic Assisted Therapy Research and Science Therapy Ethics

Telemedicine models for supporting psychedelic therapy

Panel explores how telemedicine can enhance psychedelic therapy practice, discussing benefits and risks of virtual care in light of pandemic-induced regulatory changes and improved meeting tech.

Juan Pablo Cappello, Jonathan Sabbagh

PS2023 Harm Reduction Health Conditions Integration Psilocybin Psychedelic Assisted Therapy Research and Science

Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations

Clinicians and researchers discuss integrating psilocybin-assisted therapy into serious illness care models, presenting preliminary findings from a pilot study in hospice care for patients with terminal illness.

Yvan Beaussant, Roxanne Sholevar, Lisa Summer, Robin McKenna

PS2023 Health Conditions MDMA Psychedelic Assisted Therapy PTSD Research and Science Therapy Ethics

Trauma and psychedelic-assisted therapy

Dr. Barbara Rothbaum discusses combining MDMA with prolonged exposure therapy for PTSD, citing theoretical and translational research supporting a synergistic mechanism of action for treatment.

Barbara Rothbaum, Lynnette A. Averill

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Science Research and Science Substance Use Disorder

The Mirror Molecule: How can ketamine and other substances be both addictive and anti-addictive?

Ketamine and psilocybin show promise for health conditions but come with risks, including addiction. This talk challenges the view of drugs as neutral tools and explores their complex nature and

Elias Dakwar

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

Become a MAPS Member with a monthly donation

Related Videos